Original Source(s)
Related Content
Digoxin misses heart failure endpoint
Researchers observed fewer worsening heart failure events, but the trial did not establish a statistically significant benefit.
by Kerri Miller
October 29, 2026
-
5 min
FDA updates PAH label with trial data
In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.
September 22, 2026
-
3 min
CDC: Measles cases surpass 4,000 in 2026
CDC data show that 96% of cases are outbreak-associated, with adults accounting for 40% of cases, up from 29% in 2025.
by Teraya Smith
October 12, 2026
-
3 min